Lunai Bioworks, Inc. (LNAI) 8-K Summary

Filed October 31, 2025, detailing results from the Annual Shareholder Meeting. All four proposals were approved.

• Director Elections: Four nominees (including David Weinstein) were elected to serve until the 2026 annual meeting. The election complied with Nasdaq governance rules regarding director independence.
• Auditor Ratification: Shareholders approved the appointment of Sadler, Gibb & Associates LLC as the independent registered public accounting firm for FY ending June 30, 2026 (8.8M ‘For’ votes).
• __Incentive Plan Amendment